Michael P Dunne
biomedicine
Phylogica
Australia
Biography
Member of Phylogica which is developing next generation intracellular biological therapeutics, including its own preclinical Myc, STAT 5 and YB1 oncology inhibitor payloads, using its proprietary best-in-class cell penetrating FPPs.
Research Interest
biological therapeutics